2CG.F NANOSPHERE HEA.SCIENCES

Healthcare Biotechnology Frankfurt Exchange
0.0110 EUR
Close of Nov 11, 2026
0.0005 0.0300
Market cap
EUR 113K
P/E
-
P/B
2.03x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 2CG.F undervalued?

Graham number

The Graham number of NANOSPHERE HEA.SCIENCES cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NANOSPHERE HEA.SCIENCES fundamental analysis

No fundamental analysis for NANOSPHERE HEA.SCIENCES yet.

NANOSPHERE HEA.SCIENCES stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NANOSPHERE HEA.SCIENCES

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, animal health, and other industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.

Full company profile